Inhibitiory action of asiaticoside on collagen-induced arthritis in mice

Yaoxue Xuebao

Volumn 42, Issue 7, 2007, Pages 698-703

  Li, Hong Zhong ^a   Wan, Jing Yuan ^a   Zhang, Li ^b   Zhou, Qi Xin ^a   Luo, Fu Ling ^a   Zhang, Zhuo ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Asiaticoside; Collagen induced arthritis; Inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; ASIATICOSIDE; COLLAGEN TYPE 2; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 6; PROSTAGLANDIN E2; PTGS2 PROTEIN, MOUSE; TRITERPENE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANKLE; ARTHRITIS; ARTICLE; BLOOD; CELL PROLIFERATION; CENTELLA ASIATICA; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DBA MOUSE; DRUG EFFECT; ISOLATION AND PURIFICATION; LYMPHOCYTE; MALE; MEDICINAL PLANT; METABOLISM; MOUSE; PATHOLOGY; SPLEEN;

ANIMALS; ANKLE JOINT; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; CELL PROLIFERATION; CENTELLA; COLLAGEN TYPE II; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; INTERLEUKIN-6; LYMPHOCYTES; MALE; MICE; MICE, INBRED DBA; PLANTS, MEDICINAL; SPLEEN; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548386616     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gabriel SE. The epidemiology of rheumatoid arthritis [J]. Rheum Dis Clin North Am, 2001, 27:269-282.
2. Mabato SB, Sahu NP, Luger P, et al. Stereochemistry of a trisaccharide from Centella asiatica. X-Ray determination of the structure of asiaticoside [J]. J Chem Soc Perkin Trans II, 1987:1509.
3. Tian CW. The medicine and cosmetics containing Centalla asiatica extractives used for anti-inflammation and cutis-aging prevention [J]. World Notes Plant Med, 2005, 20:88-89.
4. Ming ZJ, Sun M. Study on antiinflammation effect of asiaticoside [J]. Chin J Tradit Med Sci Technol, 2002, 9:62.
5. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis [J]. J Exp Med, 1977, 146:857-868.
6. Banda NK, Kraus D, Vondracek A, et al. Mechanisms of effects of complement inhibition in murine collagen-induced arthritis [J]. Arthritis Rheum, 2002, 46: 3065-3075.
7. Tomita T, Kakiuchi Y, Tsao PS. THR0921, a novel peroxisome proliferators activated receptor gamma agonist, reduces the severity of collagen-induced arthritis [J]. Arthritis Res Ther, 2005, 8:10-18.
8. Haqqi TM, Anthony DD, Gupta S, et al. Prevention of collagen-induced arthritis in mice by a polyphenols fraction from green tea [J]. Proc Natl Acad Sci, 1999, 96:4524-4529.
9. Zhang LL, Shen YX, Wei W. Relation between animal models of RA and clinic [J]. Chin Pharmacol Bull, 2002, 18:502-506.
10. Brand DD, Myers LK, Whittington KB. Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model [J]. J Immunol, 2002, 168:490-498.
11. Lipsky PE. Role of cyclooxygenase-1 and -2 in health and disease [J]. Am J Orthop, 1999, 28:8-12.
12. Ochi T, Ohkubo Y, Mutoh S. Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1 J mice [J]. Biochem Pharmacol, 2003, 66:1055-1060.
13. Akaogi J, Nozaki T, Satoh M, et al. Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy [J]. Endocr Metab Immune Disord Drug Targets, 2006, 6:383-394.
14. Keystone EC. Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis [J]. Rheum Dis Clin North Am, 2001, 27:427-443.
15. Benedetti F, Martini A, Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis [J]. Arthritis Rheum, 2005, 52:687-693.